Identification and characterization of PEBP as a calpain substrate (Q40224274)

18 September 2017

title

Identification and characterization of PEBP as a calpain substrate (English)

1 reference

18 September 2017

Qinghua Chen

1

1 reference

18 September 2017

Susan Wang

2

1 reference

18 September 2017

Stephanie N Thompson

3

1 reference

18 September 2017

Edward D Hall

4

1 reference

18 September 2017

Rodney P Guttmann

5

1 reference

18 September 2017

language of work or name

English

0 references

publication date

2 October 2006

1 reference

Journal of Neurochemistry

18 September 2017

published in

1 reference

18 September 2017

volume

99

1 reference

18 September 2017

issue

4

1 reference

18 September 2017

page(s)

1133-1141

1 reference

Calpain activation in neurodegenerative diseases: confocal immunofluorescence study with antibodies specifically recognizing the active form of calpain 2.

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Postischemic administration of AK275, a calpain inhibitor, provides substantial protection against focal ischemic brain damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Impairment of the ubiquitin-proteasome system by protein aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Src-mediated tyrosine phosphorylation of NR2 subunits of N-methyl-D-aspartate receptors protects from calpain-mediated truncation of their C-terminal domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Calpain-mediated regulation of NMDA receptor structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Regulating cell migration: calpains make the cut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Mitochondrial proteomic analysis of a cell line model of familial amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Inhibition of calpain cleavage of huntingtin reduces toxicity: accumulation of calpain/caspase fragments in the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Perikaryal accumulation and proteolysis of neurofilament proteins in the post-mortem rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Calcium-dependent cleavage of endogenous wild-type huntingtin in primary cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Specific proteolysis of the NR2 subunit at multiple sites by calpain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Proteolysis of the N-methyl-d-aspartate receptor by calpain in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Spatial and temporal characteristics of neurodegeneration after controlled cortical impact in mice: more than a focal brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

The phosphatidylethanolamine-binding protein is the prototype of a novel family of serine protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Neuroprotection with a calpain inhibitor in a model of focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Calcium-activated proteolysis in rat neocortex induced by transient focal ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Regulation of Cell Migration by the Calcium-dependent Protease Calpain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Calpains: Intact and active?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Proteolysis of tau by calpain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Huntingtin is degraded to small fragments by calpain after ischemic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

The novel calpain inhibitor SJA6017 improves functional outcome after delayed administration in a mouse model of diffuse brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Identification of a short form of ubiquitin-specific protease 3 that is a repressor of rat glutathione S-transferase gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Oxidation of thiol-proteases in the hippocampus of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Six-Hour Window of Opportunity for Calpain Inhibition in Focal Cerebral Ischemia in Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Calpain activity regulates the cell surface distribution of amyloid precursor protein. Inhibition of calpains enhances endosomal generation of beta-cleaved C-terminal APP fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Oxidative stress inhibits ionomycin-mediated cell death in cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Glutamate receptor antagonists inhibit calpain-mediated cytoskeletal proteolysis in focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Distinct cleavage patterns of normal and pathologic forms of alpha-synuclein by calpain I in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Intracellular Ca2 -dependent protease (CALPAIN) and its high-molecular-weight endogenous inhibitor (CALPASTATIN)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Calpain activity in the rat brain after transient forebrain ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Cross-talk between calpain and caspase proteolytic systems during neuronal apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Probability-based protein identification by searching sequence databases using mass spectrometry data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Microtubular proteolysis in focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

A calpain inhibitor attenuates cortical cytoskeletal protein loss after experimental traumatic brain injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Protective effects of calpain inhibitors against neuronal damage caused by cytotoxic hypoxia in vitro and ischemia in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Purification from Synaptosomal Plasma Membranes of Calpain I, a Thiol Protease Activated by Micromolar Calcium Concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Brain fodrin: substrate for calpain I, an endogenous calcium-activated protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Aggregated and monomeric alpha-synuclein bind to the S6' proteasomal protein and inhibit proteasomal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Cyclosporin A attenuates acute mitochondrial dysfunction following traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

High levels of hippocampal cholinergic neurostimulating peptide (HCNP) in the CSF of some patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Calmodulin-binding proteins as calpain substrates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Calpain-dependent endoproteolytic cleavage of PrPSc modulates scrapie prion propagation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Specific increase in amyloid beta-protein 42 secretion ratio by calpain inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Evaluation of conditions for calpain inhibition in the rat spinal cord: effective postinjury inhibition with intraspinal MDL28170 microinjection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

Calpain inhibitor I increases beta-amyloid peptide production by inhibiting the degradation of the substrate of gamma-secretase. Evidence that substrate availability limits beta-amyloid peptide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1471-4159.2006.04160.X

10.1111/J.1471-4159.2006.04160.X

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference